Medtronic Announces Expanded CE Mark Indication For Its Affera Mapping And Ablation System With Sphere-9 Catheter To Treat Ventricular Arrhythmias, Including Ventricular Tachycardia And Premature Ventricular Complexes

뉴스 본문을 불러오고 있어요.

Medtronic Announces Expanded CE Mark Indication For Its Affera Mapping And Ablation System With Sphere-9 Catheter To Treat Ventricular Arrhythmias, Including Ventricular Tachycardia And Premature Ventricular Complexes | 웨이프 WAPE

Medtronic Announces Expanded CE Mark Indication For Its Affera Mapping And Ablation System With Sphere-9 Catheter To Treat Ventricular Arrhythmias, Including Ventricular Tachycardia And Premature Ventricular Complexes

기사 요약

관련 종목

댓글 —